Upregulated CAF-derived versican can subsequently enhance cancer cell motility and invasion by activating the nuclear factor-κB (NF-κB) signaling pathway and inducing the expressions of CD44, MMP-9, and hyaluronan-mediated motility receptor (HMMR) in the surrounding tumor microenvironment [81]. This evidence concerns the gene MMP9 and neoplasm.